A review of oscillating field stimulation to treat human spinal cord injury

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: To report the results of use of a human oscillating field stimulator (OFS) in a phase 1 trial of 14 human patients with complete motor and sensory spinal cord injury. Methods: Entry criteria were complete spinal cord injury between C5 and T10 in patients 18-65 years old with no transection on magnetic resonance imaging. All patients received the National Acute Spinal Cord Injury Study III methylprednisolone protocol. Cord compression or instability was treated before entry. All patient injuries remained complete (based on American Spinal Cord Injury scoring) with no somatosensory evoked potentials (SSEPs) below the injury after surgery or for 48 hours. All patients were implanted with the OFS within 18 days. Patients were checked every 2 weeks after implantation. The OFS was explanted at 15 weeks. Independent neurologic examinations (American Spinal Cord Injury score, visual analog scale for pain, and SSEPs) were done at 6 weeks, 6 months, and 1 year. Statistical analyses were done by Wilcoxon rank sum test and analysis of variance (ANOVA). Results: There were no complications at insertion, and one wound infection occurred after explant for a 3.5% infection rate. One patient was lost to follow-up after 6 months. All 14 patients had a mean visual analog scale score of 8 at implant and 2 at 6 months, and 13 remained a mean score of 2 at 1 year. Mean improvement in light touch score at 1 year was 25.9 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in pinprick score at 1 year was 15.2 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in motor score was 6.9 (ANOVA, P < 0.01; Wilcoxon, P = 0.02). Of eight patients with cervical cord injuries, six had improvement in arm SSEPs, and one recovered a tibial SSEP. Of six patients with thoracic injuries, one recovered an abnormal lower SSEP. Conclusions: Treatment of human spinal cord injury with an OFS is safe, reliable, and easy. Compared with National Acute Spinal Cord Injury Study III compliant paralyzed patients, our results suggest efficacy.

Original languageEnglish
Pages (from-to)830-835
Number of pages6
JournalWorld Neurosurgery
Volume81
Issue number5-6
DOIs
StatePublished - 2014

Fingerprint

Spinal Cord Injuries
Somatosensory Evoked Potentials
Analysis of Variance
Nonparametric Statistics
Wounds and Injuries
Thoracic Injuries
Lost to Follow-Up
Methylprednisolone
Neurologic Examination
Touch
Wound Infection
Pain Measurement
Visual Analog Scale
Magnetic Resonance Imaging

Keywords

  • Oscillating field stimulation
  • Spinal cord injury
  • Spinal cord injury treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

A review of oscillating field stimulation to treat human spinal cord injury. / Shapiro, Scott.

In: World Neurosurgery, Vol. 81, No. 5-6, 2014, p. 830-835.

Research output: Contribution to journalArticle

@article{738040eb128e469eb192e4d794fb5778,
title = "A review of oscillating field stimulation to treat human spinal cord injury",
abstract = "Objective: To report the results of use of a human oscillating field stimulator (OFS) in a phase 1 trial of 14 human patients with complete motor and sensory spinal cord injury. Methods: Entry criteria were complete spinal cord injury between C5 and T10 in patients 18-65 years old with no transection on magnetic resonance imaging. All patients received the National Acute Spinal Cord Injury Study III methylprednisolone protocol. Cord compression or instability was treated before entry. All patient injuries remained complete (based on American Spinal Cord Injury scoring) with no somatosensory evoked potentials (SSEPs) below the injury after surgery or for 48 hours. All patients were implanted with the OFS within 18 days. Patients were checked every 2 weeks after implantation. The OFS was explanted at 15 weeks. Independent neurologic examinations (American Spinal Cord Injury score, visual analog scale for pain, and SSEPs) were done at 6 weeks, 6 months, and 1 year. Statistical analyses were done by Wilcoxon rank sum test and analysis of variance (ANOVA). Results: There were no complications at insertion, and one wound infection occurred after explant for a 3.5{\%} infection rate. One patient was lost to follow-up after 6 months. All 14 patients had a mean visual analog scale score of 8 at implant and 2 at 6 months, and 13 remained a mean score of 2 at 1 year. Mean improvement in light touch score at 1 year was 25.9 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in pinprick score at 1 year was 15.2 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in motor score was 6.9 (ANOVA, P < 0.01; Wilcoxon, P = 0.02). Of eight patients with cervical cord injuries, six had improvement in arm SSEPs, and one recovered a tibial SSEP. Of six patients with thoracic injuries, one recovered an abnormal lower SSEP. Conclusions: Treatment of human spinal cord injury with an OFS is safe, reliable, and easy. Compared with National Acute Spinal Cord Injury Study III compliant paralyzed patients, our results suggest efficacy.",
keywords = "Oscillating field stimulation, Spinal cord injury, Spinal cord injury treatment",
author = "Scott Shapiro",
year = "2014",
doi = "10.1016/j.wneu.2012.11.039",
language = "English",
volume = "81",
pages = "830--835",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "5-6",

}

TY - JOUR

T1 - A review of oscillating field stimulation to treat human spinal cord injury

AU - Shapiro, Scott

PY - 2014

Y1 - 2014

N2 - Objective: To report the results of use of a human oscillating field stimulator (OFS) in a phase 1 trial of 14 human patients with complete motor and sensory spinal cord injury. Methods: Entry criteria were complete spinal cord injury between C5 and T10 in patients 18-65 years old with no transection on magnetic resonance imaging. All patients received the National Acute Spinal Cord Injury Study III methylprednisolone protocol. Cord compression or instability was treated before entry. All patient injuries remained complete (based on American Spinal Cord Injury scoring) with no somatosensory evoked potentials (SSEPs) below the injury after surgery or for 48 hours. All patients were implanted with the OFS within 18 days. Patients were checked every 2 weeks after implantation. The OFS was explanted at 15 weeks. Independent neurologic examinations (American Spinal Cord Injury score, visual analog scale for pain, and SSEPs) were done at 6 weeks, 6 months, and 1 year. Statistical analyses were done by Wilcoxon rank sum test and analysis of variance (ANOVA). Results: There were no complications at insertion, and one wound infection occurred after explant for a 3.5% infection rate. One patient was lost to follow-up after 6 months. All 14 patients had a mean visual analog scale score of 8 at implant and 2 at 6 months, and 13 remained a mean score of 2 at 1 year. Mean improvement in light touch score at 1 year was 25.9 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in pinprick score at 1 year was 15.2 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in motor score was 6.9 (ANOVA, P < 0.01; Wilcoxon, P = 0.02). Of eight patients with cervical cord injuries, six had improvement in arm SSEPs, and one recovered a tibial SSEP. Of six patients with thoracic injuries, one recovered an abnormal lower SSEP. Conclusions: Treatment of human spinal cord injury with an OFS is safe, reliable, and easy. Compared with National Acute Spinal Cord Injury Study III compliant paralyzed patients, our results suggest efficacy.

AB - Objective: To report the results of use of a human oscillating field stimulator (OFS) in a phase 1 trial of 14 human patients with complete motor and sensory spinal cord injury. Methods: Entry criteria were complete spinal cord injury between C5 and T10 in patients 18-65 years old with no transection on magnetic resonance imaging. All patients received the National Acute Spinal Cord Injury Study III methylprednisolone protocol. Cord compression or instability was treated before entry. All patient injuries remained complete (based on American Spinal Cord Injury scoring) with no somatosensory evoked potentials (SSEPs) below the injury after surgery or for 48 hours. All patients were implanted with the OFS within 18 days. Patients were checked every 2 weeks after implantation. The OFS was explanted at 15 weeks. Independent neurologic examinations (American Spinal Cord Injury score, visual analog scale for pain, and SSEPs) were done at 6 weeks, 6 months, and 1 year. Statistical analyses were done by Wilcoxon rank sum test and analysis of variance (ANOVA). Results: There were no complications at insertion, and one wound infection occurred after explant for a 3.5% infection rate. One patient was lost to follow-up after 6 months. All 14 patients had a mean visual analog scale score of 8 at implant and 2 at 6 months, and 13 remained a mean score of 2 at 1 year. Mean improvement in light touch score at 1 year was 25.9 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in pinprick score at 1 year was 15.2 points (ANOVA, P < 0.001; Wilcoxon, P = 0.02). Mean improvement in motor score was 6.9 (ANOVA, P < 0.01; Wilcoxon, P = 0.02). Of eight patients with cervical cord injuries, six had improvement in arm SSEPs, and one recovered a tibial SSEP. Of six patients with thoracic injuries, one recovered an abnormal lower SSEP. Conclusions: Treatment of human spinal cord injury with an OFS is safe, reliable, and easy. Compared with National Acute Spinal Cord Injury Study III compliant paralyzed patients, our results suggest efficacy.

KW - Oscillating field stimulation

KW - Spinal cord injury

KW - Spinal cord injury treatment

UR - http://www.scopus.com/inward/record.url?scp=84902162932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902162932&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2012.11.039

DO - 10.1016/j.wneu.2012.11.039

M3 - Article

C2 - 23159651

AN - SCOPUS:84902162932

VL - 81

SP - 830

EP - 835

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 5-6

ER -